FOOT & ANKLE
Improved foot-specific health with corticosteroid injection for Morton neuroma
J Bone Joint Surg Am. 2013 May 1;95(9):790-8. doi: 10.2106/JBJS.I.01780131 patients diagnosed with Morton's neuroma were randomized to determine the efficacy of a corticosteroid injection as a treatment option. Participants were allocated to receive an injection of methylprednisolone and lignocaine, or an injection of lignocaine alone (control). Blinded evaluation of outcomes was performed for 3 months post-injection. Results after 3 months indicated that foot-specific health was significantly better in the corticosteroid group compared to control. Injection of methylprednisolone was also associated with significant improvement in a number of dimensions of pain when compared to control injections.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
